Diabetic painful neuropathy: current and future treatment options (Q36757592)

16 August 2017

1 reference

title

Diabetic painful neuropathy: current and future treatment options (English)

1 reference

16 August 2017

M Sam Chong

1

1 reference

PubMed ID

17352515

16 August 2017

Joan Hester

series ordinal

2

1 reference

16 August 2017

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

67

1 reference

16 August 2017

569-585

1 reference

16 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200767040-00006

16 August 2017

0 references

cites work

Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767040-00006

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767040-00006

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767040-00006

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767040-00006

Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767040-00006

Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767040-00006

The number needed to treat: a clinically useful measure of treatment effect

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767040-00006

Using numerical results from systematic reviews in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767040-00006

Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767040-00006

Phenytoin in the treatment of diabetic symmetrical polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767040-00006

High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200767040-00006

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

21 January 2018

1 reference

12 December 2020

Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control

1 reference

12 December 2020

EFNS guidelines on neuropathic pain assessment

1 reference

12 December 2020

Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study

1 reference

12 December 2020

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

1 reference

12 December 2020

Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol�): Double blind crossover trial

1 reference

12 December 2020

Skin biopsy as a tool to assess distal small fiber innervation in diabetic neuropathy

1 reference

12 December 2020

Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies

1 reference

12 December 2020

Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study

1 reference

12 December 2020

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

1 reference

12 December 2020

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial

1 reference

12 December 2020

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

1 reference

12 December 2020

Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial

1 reference

12 December 2020

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

1 reference

12 December 2020

Diabetic peripheral neuropathy: amelioration of pain with transcutaneous electrostimulation

1 reference

12 December 2020

A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain

1 reference

12 December 2020

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

1 reference

12 December 2020

Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes

1 reference

12 December 2020

Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.

1 reference

12 December 2020

Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications

1 reference

12 December 2020

The diabetic neuropathies

1 reference

12 December 2020

The relationship between blood glucose excursions and painful diabetic peripheral neuropathy: a pilot study

1 reference

12 December 2020

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy

1 reference

12 December 2020

Pregabalin-withdrawal encephalopathy and splenial edema: a link to high-altitude illness?

1 reference

12 December 2020

Double blind study of the effects of diphenylhydantoin sodium on diabetic neuropathy

1 reference

12 December 2020

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study

1 reference

12 December 2020

Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain

1 reference

12 December 2020

The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs.

1 reference

12 December 2020

Imipramine Treatment of Painful Diabetic Neuropathy

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial

1 reference

12 December 2020

Duloxetine vs. placebo in patients with painful diabetic neuropathy

1 reference

12 December 2020

Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes

1 reference

12 December 2020

A case of painful progressive peripheral neuropathy after successful pancreas transplantation

1 reference

12 December 2020

Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials

1 reference

12 December 2020

The prevention of diabetic microvascular complications of diabetes: is there a role for lipid lowering?

1 reference

12 December 2020

Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy

1 reference

12 December 2020

Clinical investigation of epalrestat, an aldose reductase inhibitor, on diabetic neuropathy in Japan: multicenter study. Diabetic Neuropathy Study Group in Japan

1 reference

12 December 2020

Zonisamide in the treatment of painful diabetic neuropathy: a randomized, double-blind, placebo-controlled pilot study

1 reference

12 December 2020

Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials

1 reference

12 December 2020

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis

1 reference

12 December 2020

Gabapentin vs. amitriptyline in painful diabetic neuropathy: an open-label pilot study

1 reference

12 December 2020

Gabapentin for neuropathic pain: systematic review of controlled and uncontrolled literature.

1 reference

12 December 2020

Therapeutic outcome in neuropathic pain: relationship to evidence of nervous system lesion.

1 reference

12 December 2020

The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy

1 reference

12 December 2020

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

1 reference

12 December 2020

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

1 reference

12 December 2020

Morphine, gabapentin, or their combination for neuropathic pain.

1 reference

12 December 2020

Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study

1 reference

12 December 2020

Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. The Capsaicin Study Group

1 reference

12 December 2020

Electrical spinal cord stimulation in the long-term treatment of chronic painful diabetic neuropathy

1 reference

12 December 2020

Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study

1 reference

12 December 2020

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

1 reference

12 December 2020

Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens

1 reference

12 December 2020

Efficacy and safety of nonsteroidal anti-inflammatory drugs in the therapy of diabetic neuropathy

1 reference

12 December 2020

Painful sensory polyneuropathy associated with impaired glucose tolerance

1 reference

12 December 2020

Sodium valproate in painful diabetic polyneuropathy

1 reference

12 December 2020

[Effects of kidney and pancreas transplantation on neurophysiological rates of polyneuropathy and autonomous cardiac function in diabetic patients with end-stage renal disease]

1 reference

12 December 2020

Quantitative sensory testing: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

12 December 2020

Prevalence of peripheral neuropathy in type 2 diabetic patients attending a diabetes center in Turkey.

1 reference

12 December 2020

Advances in opioid pharmacology

1 reference

12 December 2020

Polyol pathway and diabetic peripheral neuropathy

1 reference

12 December 2020

Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study

1 reference

12 December 2020

Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial

1 reference

12 December 2020

Algorithm for neuropathic pain treatment: an evidence based proposal.

1 reference

12 December 2020

Treatment of chronic painful diabetic neuropathy with isosorbide dinitrate spray: a double-blind placebo-controlled cross-over study

1 reference

12 December 2020

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

1 reference

12 December 2020

Impact of low frequency transcutaneous electrical nerve stimulation on symptomatic diabetic neuropathy using the new Salutaris device.

1 reference

12 December 2020

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

1 reference

12 December 2020

Concentration-response relationship in imipramine treatment of diabetic neuropathy symptoms

1 reference

12 December 2020

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

1 reference

12 December 2020

Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study

1 reference

12 December 2020

Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function

1 reference

12 December 2020

A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy.

1 reference

12 December 2020

Use of levodopa to relieve pain from painful symmetrical diabetic polyneuropathy

1 reference

12 December 2020

10.2165/00003495-200767040-00006

Identifiers

DOI

1 reference

PubMed ID

17352515

Dimensions Publication ID

16 August 2017

0 references

1 reference

PubMed ID

17352515